English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Monday, July 31, 2023
China Medical System Once Again Received MSCI-ESG 'AA' Rating, Leading the Industry in ESG Management
Thursday, June 29, 2023
China Medical System Included in the First 'Sustainability Yearbook (China)' of S&P Global
Monday, June 12, 2023
China Medical System: The first 'Diazepam Nasal Spray' Approved for Marketing in China
China Medical System: The first 'Diazepam Nasal Spray' Approved for Marketing in China
Tuesday, May 30, 2023
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China
Monday, December 19, 2022
Gelonghui Reports CMS' Successful Phase III Study of Methylthioninium Chloride Enteric-coated Sustained-release Tablets
Friday, November 18, 2022
China Medical System (867.HK) S&P Global CSA Score Achieved Significant Improvement, Leading the Industry Globally
Friday, August 26, 2022
CMS Releases Its 2022 Interim Report, Achieves Sustained Growth with Its Platform Strategy
Tuesday, September 6, 2022
CMS Releases Its 2022 Interim Report, Achieves Sustained Growth with Its Platform Strategy

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575